Cells

SMOC reserves over 100 commonly used tumor cell lines, mostly derived from the ATCC and the Chinese Academy of Sciences Collection Committee cell bank. These cell lines can be used to offer technical services such as cell line knock-in/knock-out, cell proliferation/apoptosis, and cell migration/invasion.

Animal Model (These include, but are not limited to, the following data.)

Strain State (Con:Construction; Expr:Validation of target gene expression; TC:Validation of tumorigenic capacity; Parma:Validation of pharmacodynamic assays.)

Cell Line
Cancer Type
Category
Organism
Animal Model
Strain State
Con
Expr
TC
Parma
Neuro-2a N/A Wild-type Mus musculus
  • -
  • -
  • -
  • -
  • -
Neuro-2a-Luc Cerebroma Reporter-labeled Mus musculus
  • -
Neuro-2a-RFP Cerebroma Reporter-labeled Mus musculus
  • -
NIH/3T3 N/A Wild-type Mus musculus
  • -
  • -
  • -
  • -
  • -
NIH/3T3-hFAP N/A Humanized Drug Targets Mus musculus
  • -
NIH:OVCAR-3 [OVCAR3] Ovarian Wild-type Homo sapiens M-NSG
  • -
  • -
  • -
  • -
  • -
  • -
NK-92 MI Lymphoma Wild-type Homo sapiens
  • -
  • -
  • -
  • -
  • -
NUGC4 Stomach Wild-type Homo sapiens M-NSG
  • -
  • -
  • -
  • -
  • -
  • -
NUGC4-hCLDN18.2-Tg Stomach Humanized Drug Targets Mus musculus
  • -
  • -
  • -
  • -
NUGC4-Luc Stomach Reporter-labeled Homo sapiens
  • -
  • -
  • -
  • -
  • -
  • -
OCI-AML-3 Leukemia Wild-type Homo sapiens
  • -
  • -
  • -
  • -
  • -
OCI-AML-3-Luc Leukemia Reporter-labeled Homo sapiens
  • -
  • -
  • -
  • -
  • -
  • -
OCI-LY3 Leukemia Wild-type Homo sapiens
  • -
  • -
  • -
  • -
  • -
OCI-LY3-Luc Lymphoma Reporter-labeled Homo sapiens
  • -
OCI-LY7 Leukemia Wild-type Homo sapiens M-NSG
  • -
  • -
  • -
  • -
  • -
OCI-LY7-Luc Lymphoma Reporter-labeled Homo sapiens
  • -
OE19 Pharyngeal Wild-type Homo sapiens
  • -
  • -
  • -
  • -
  • -
  • -
OV90 Ovarian Wild-type Homo sapiens
  • -
  • -
  • -
  • -
  • -
  • -
OVCAR-3-Luc Ovarian Reporter-labeled Homo sapiens
  • -
P815 N/A Wild-type Mus musculus
  • -
  • -
  • -
  • -
  • -

Email Back to top